Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, novembre 20
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Pulse Biosciences Inc
PLSE
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$45.57
1.16
2.61%
Dern. MÀJ: Nov 20, 1:23 PM
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Pulse Biosciences Financials
Pulse Biosciences (PLSE) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Pulse Biosciences Q3 EPS $(0.32) Beats $(0.36) Estimate, Sales $395.000K Miss $516.667K Estimate
Benzinga Newsdesk
PRO
Pulse Biosciences Q2 EPS $(0.36), Inline, Sales $434.000K Miss $533.333K Estimate
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For May 4, 2026
Benzinga Insights
PRO
Pulse Biosciences Q1 EPS $(0.27) Beats $(0.32) Estimate, Sales $401.000K Beat $400.000K Estimate
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 12.9 percent. This is a 8 percent decrease over losses of $(0.25) per share from the
Benzinga Newsdesk
Pulse Biosciences Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Pulse Biosciences Q4 EPS $(0.26) Beats $(0.31) Estimate, Sales $264.000K Beat $250.000K Estimate
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 16.13 percent increase over losses of $(0.31) per share from
Benzinga Newsdesk